Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Code:
NCT05285891
Conditions
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Ocrelizumab
Placebo for Ocrelizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations